Kevin Ess
Concepts (334)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tuberous Sclerosis | 22 | 2025 | 55 | 4.770 |
Why?
| | Tumor Suppressor Proteins | 13 | 2023 | 320 | 3.180 |
Why?
| | Induced Pluripotent Stem Cells | 14 | 2025 | 248 | 1.610 |
Why?
| | TOR Serine-Threonine Kinases | 10 | 2023 | 415 | 1.470 |
Why?
| | Sirolimus | 7 | 2024 | 277 | 1.040 |
Why?
| | Astrocytoma | 3 | 2021 | 128 | 1.010 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 3 | 2025 | 55 | 1.010 |
Why?
| | Neural Stem Cells | 7 | 2019 | 158 | 0.960 |
Why?
| | Tumor Suppressor Protein p53 | 5 | 2017 | 525 | 0.950 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 9 | 2025 | 129 | 0.910 |
Why?
| | Multiprotein Complexes | 4 | 2013 | 168 | 0.890 |
Why?
| | Neurons | 8 | 2020 | 1601 | 0.870 |
Why?
| | Hemiplegia | 3 | 2025 | 21 | 0.850 |
Why?
| | Brain | 9 | 2024 | 2792 | 0.850 |
Why?
| | Epilepsy | 5 | 2021 | 335 | 0.810 |
Why?
| | Signal Transduction | 14 | 2023 | 5086 | 0.800 |
Why?
| | Zebrafish | 6 | 2023 | 496 | 0.750 |
Why?
| | Cell Differentiation | 10 | 2025 | 1992 | 0.720 |
Why?
| | Epilepsy, Generalized | 1 | 2021 | 19 | 0.700 |
Why?
| | Mosaicism | 1 | 2021 | 74 | 0.680 |
Why?
| | White Matter | 4 | 2017 | 144 | 0.650 |
Why?
| | Loss of Heterozygosity | 1 | 2017 | 51 | 0.550 |
Why?
| | Neurogenesis | 3 | 2017 | 153 | 0.520 |
Why?
| | Cellular Reprogramming | 1 | 2017 | 98 | 0.520 |
Why?
| | Autistic Disorder | 1 | 2019 | 206 | 0.500 |
Why?
| | Heterozygote | 2 | 2017 | 305 | 0.500 |
Why?
| | Brain Neoplasms | 2 | 2021 | 1267 | 0.480 |
Why?
| | Autism Spectrum Disorder | 1 | 2021 | 404 | 0.480 |
Why?
| | Diffusion Tensor Imaging | 2 | 2015 | 76 | 0.470 |
Why?
| | Gene Deletion | 2 | 2013 | 388 | 0.430 |
Why?
| | Everolimus | 4 | 2025 | 110 | 0.430 |
Why?
| | Mutation | 9 | 2025 | 3987 | 0.420 |
Why?
| | Multiple Acyl Coenzyme A Dehydrogenase Deficiency | 1 | 2013 | 2 | 0.410 |
Why?
| | Electron-Transferring Flavoproteins | 1 | 2013 | 4 | 0.410 |
Why?
| | Zebrafish Proteins | 2 | 2013 | 287 | 0.400 |
Why?
| | Gene Knock-In Techniques | 1 | 2013 | 56 | 0.400 |
Why?
| | Carrier Proteins | 4 | 2015 | 737 | 0.390 |
Why?
| | Mice, Knockout | 12 | 2019 | 3028 | 0.390 |
Why?
| | Astrocytes | 5 | 2024 | 216 | 0.390 |
Why?
| | Regenerative Medicine | 1 | 2013 | 52 | 0.390 |
Why?
| | Kidney Tubules, Distal | 1 | 2012 | 5 | 0.380 |
Why?
| | Mitochondrial Diseases | 1 | 2013 | 91 | 0.380 |
Why?
| | Disease Models, Animal | 13 | 2017 | 4315 | 0.370 |
Why?
| | Neuroglia | 2 | 2011 | 173 | 0.370 |
Why?
| | Gene Silencing | 1 | 2013 | 196 | 0.370 |
Why?
| | Immunosuppressive Agents | 2 | 2019 | 849 | 0.370 |
Why?
| | Animals | 35 | 2025 | 37217 | 0.370 |
Why?
| | Nerve Fibers, Myelinated | 1 | 2012 | 48 | 0.370 |
Why?
| | Seizures | 4 | 2021 | 431 | 0.370 |
Why?
| | Rapamycin-Insensitive Companion of mTOR Protein | 4 | 2017 | 28 | 0.360 |
Why?
| | Stem Cell Transplantation | 1 | 2013 | 184 | 0.360 |
Why?
| | Corpus Callosum | 1 | 2012 | 70 | 0.360 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2015 | 462 | 0.340 |
Why?
| | Mice | 24 | 2025 | 17814 | 0.340 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2013 | 333 | 0.340 |
Why?
| | Cilia | 1 | 2012 | 172 | 0.340 |
Why?
| | Blood-Brain Barrier | 2 | 2024 | 141 | 0.340 |
Why?
| | Myelin Sheath | 3 | 2017 | 164 | 0.340 |
Why?
| | Interneurons | 1 | 2011 | 122 | 0.330 |
Why?
| | Codon, Nonsense | 1 | 2010 | 43 | 0.330 |
Why?
| | Nervous System Diseases | 1 | 2013 | 273 | 0.320 |
Why?
| | Trans-Activators | 4 | 2012 | 385 | 0.310 |
Why?
| | Cerebral Cortex | 4 | 2020 | 452 | 0.310 |
Why?
| | Humans | 47 | 2025 | 138651 | 0.290 |
Why?
| | Mutant Proteins | 2 | 2023 | 102 | 0.280 |
Why?
| | Alleles | 3 | 2017 | 887 | 0.270 |
Why?
| | Neurobiology | 1 | 2006 | 14 | 0.240 |
Why?
| | Carcinogenesis | 2 | 2019 | 215 | 0.230 |
Why?
| | Child | 12 | 2025 | 21921 | 0.230 |
Why?
| | Mechanistic Target of Rapamycin Complex 2 | 3 | 2017 | 62 | 0.230 |
Why?
| | Electroencephalography | 2 | 2021 | 444 | 0.220 |
Why?
| | Huntington Disease | 2 | 2016 | 63 | 0.220 |
Why?
| | Proto-Oncogene Proteins | 3 | 1999 | 620 | 0.210 |
Why?
| | Cell Culture Techniques | 2 | 2019 | 364 | 0.210 |
Why?
| | Cells, Cultured | 7 | 2020 | 4181 | 0.210 |
Why?
| | Proteins | 4 | 2015 | 1006 | 0.200 |
Why?
| | Transcription Factors | 4 | 2012 | 1697 | 0.200 |
Why?
| | Arrhythmias, Cardiac | 1 | 2025 | 329 | 0.190 |
Why?
| | Ubiquitin-Protein Ligases | 2 | 2014 | 174 | 0.190 |
Why?
| | Fatty Acids | 1 | 2025 | 444 | 0.180 |
Why?
| | Embryonic and Fetal Development | 2 | 1999 | 93 | 0.180 |
Why?
| | Oncogenes | 2 | 1999 | 118 | 0.170 |
Why?
| | Thymus Gland | 3 | 1999 | 314 | 0.170 |
Why?
| | Hereditary Central Nervous System Demyelinating Diseases | 1 | 2020 | 3 | 0.170 |
Why?
| | Mitochondria | 4 | 2015 | 955 | 0.170 |
Why?
| | Gene Expression Profiling | 2 | 2005 | 1746 | 0.160 |
Why?
| | GTPase-Activating Proteins | 1 | 2020 | 82 | 0.160 |
Why?
| | Endothelial Cells | 3 | 2025 | 791 | 0.160 |
Why?
| | DNA Methylation | 1 | 2025 | 629 | 0.160 |
Why?
| | NAV1.1 Voltage-Gated Sodium Channel | 1 | 2019 | 18 | 0.160 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2023 | 334 | 0.160 |
Why?
| | Immunization | 1 | 2021 | 405 | 0.150 |
Why?
| | Gene Expression Regulation, Developmental | 5 | 2017 | 873 | 0.150 |
Why?
| | Lateral Ventricles | 1 | 2019 | 32 | 0.150 |
Why?
| | Female | 16 | 2025 | 73763 | 0.150 |
Why?
| | Polycystic Kidney Diseases | 1 | 2019 | 73 | 0.150 |
Why?
| | Drug Resistant Epilepsy | 1 | 2020 | 103 | 0.140 |
Why?
| | Aquaporin 4 | 1 | 2019 | 97 | 0.140 |
Why?
| | Mutation, Missense | 1 | 2020 | 334 | 0.140 |
Why?
| | Recurrence | 1 | 2021 | 1084 | 0.140 |
Why?
| | Wnt Signaling Pathway | 2 | 2023 | 196 | 0.140 |
Why?
| | Manganese | 2 | 2014 | 56 | 0.140 |
Why?
| | Male | 14 | 2025 | 68260 | 0.140 |
Why?
| | Genes, p53 | 1 | 2017 | 67 | 0.140 |
Why?
| | Parkinson Disease | 2 | 2014 | 556 | 0.130 |
Why?
| | Membrane Potentials | 1 | 2018 | 283 | 0.130 |
Why?
| | Fibrosis | 1 | 2019 | 539 | 0.130 |
Why?
| | Phenotype | 3 | 2020 | 3139 | 0.120 |
Why?
| | Practice Guidelines as Topic | 2 | 2021 | 1567 | 0.120 |
Why?
| | Demyelinating Diseases | 1 | 2016 | 85 | 0.120 |
Why?
| | Child, Preschool | 7 | 2025 | 11158 | 0.120 |
Why?
| | Myocytes, Cardiac | 2 | 2023 | 513 | 0.120 |
Why?
| | Central Nervous System | 1 | 2017 | 263 | 0.120 |
Why?
| | Genomic Instability | 1 | 2016 | 52 | 0.120 |
Why?
| | RNA, Small Interfering | 1 | 2017 | 626 | 0.120 |
Why?
| | Infant | 6 | 2018 | 9574 | 0.110 |
Why?
| | Gene Knockdown Techniques | 1 | 2016 | 329 | 0.110 |
Why?
| | Polyesters | 1 | 2015 | 77 | 0.110 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 1 | 2014 | 65 | 0.110 |
Why?
| | Cell Line | 6 | 2015 | 2876 | 0.110 |
Why?
| | Neuroimaging | 1 | 2016 | 263 | 0.110 |
Why?
| | Chromatin | 2 | 2015 | 515 | 0.110 |
Why?
| | Cadmium | 1 | 2014 | 68 | 0.110 |
Why?
| | Flow Cytometry | 2 | 2024 | 1192 | 0.110 |
Why?
| | Protein Structure, Tertiary | 2 | 2015 | 858 | 0.110 |
Why?
| | Enhancer Elements, Genetic | 1 | 1995 | 189 | 0.110 |
Why?
| | Neoplasms, Experimental | 1 | 1995 | 174 | 0.110 |
Why?
| | Copper | 1 | 2014 | 111 | 0.110 |
Why?
| | Magnetic Resonance Imaging | 2 | 2016 | 3637 | 0.100 |
Why?
| | RNA, Messenger | 3 | 2020 | 2815 | 0.100 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2015 | 147 | 0.100 |
Why?
| | Checklist | 1 | 2014 | 104 | 0.100 |
Why?
| | Glutamic Acid | 2 | 2007 | 255 | 0.100 |
Why?
| | Brain Diseases | 1 | 2014 | 148 | 0.100 |
Why?
| | Pluripotent Stem Cells | 1 | 2014 | 80 | 0.100 |
Why?
| | Founder Effect | 1 | 2013 | 11 | 0.100 |
Why?
| | Neoplasm Invasiveness | 1 | 1995 | 501 | 0.100 |
Why?
| | Models, Theoretical | 1 | 2016 | 578 | 0.100 |
Why?
| | Abdominal Neoplasms | 1 | 2013 | 38 | 0.100 |
Why?
| | Corpus Striatum | 1 | 2014 | 176 | 0.100 |
Why?
| | Manganese Poisoning | 1 | 2012 | 1 | 0.100 |
Why?
| | Parkinson Disease, Secondary | 1 | 2012 | 7 | 0.100 |
Why?
| | Stem Cells | 3 | 2023 | 599 | 0.100 |
Why?
| | Homozygote | 1 | 2013 | 201 | 0.100 |
Why?
| | Fibroblasts | 1 | 2017 | 1003 | 0.100 |
Why?
| | Adolescent | 7 | 2025 | 21564 | 0.100 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2013 | 60 | 0.090 |
Why?
| | Genetic Testing | 1 | 2015 | 451 | 0.090 |
Why?
| | Paired Box Transcription Factors | 1 | 2012 | 46 | 0.090 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2015 | 264 | 0.090 |
Why?
| | Chlorides | 1 | 2012 | 138 | 0.090 |
Why?
| | Exons | 1 | 2013 | 353 | 0.090 |
Why?
| | Fluorescent Antibody Technique | 1 | 2012 | 385 | 0.090 |
Why?
| | Blotting, Western | 2 | 2012 | 1230 | 0.090 |
Why?
| | Ribosomes | 1 | 2013 | 186 | 0.090 |
Why?
| | Eye Proteins | 1 | 2012 | 93 | 0.090 |
Why?
| | SOXB1 Transcription Factors | 1 | 2012 | 62 | 0.090 |
Why?
| | Blood Vessels | 1 | 2013 | 180 | 0.090 |
Why?
| | Mice, Transgenic | 2 | 2013 | 2172 | 0.090 |
Why?
| | Glioblastoma | 1 | 1995 | 341 | 0.090 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2012 | 139 | 0.090 |
Why?
| | Neovascularization, Pathologic | 1 | 2013 | 296 | 0.090 |
Why?
| | Cognition | 1 | 2019 | 1179 | 0.090 |
Why?
| | Gene-Environment Interaction | 1 | 2012 | 186 | 0.090 |
Why?
| | Quinolines | 1 | 2012 | 150 | 0.090 |
Why?
| | Cell Lineage | 2 | 2019 | 350 | 0.080 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2013 | 442 | 0.080 |
Why?
| | Cell Size | 1 | 2010 | 89 | 0.080 |
Why?
| | Liver | 3 | 2015 | 1805 | 0.080 |
Why?
| | Lung | 1 | 2023 | 4106 | 0.080 |
Why?
| | Environmental Pollutants | 1 | 2012 | 160 | 0.080 |
Why?
| | Autophagy | 1 | 2013 | 285 | 0.080 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2013 | 549 | 0.080 |
Why?
| | Polyethylene Glycols | 1 | 2015 | 631 | 0.080 |
Why?
| | Molecular Targeted Therapy | 1 | 2013 | 413 | 0.080 |
Why?
| | Embryo, Nonmammalian | 1 | 2010 | 169 | 0.080 |
Why?
| | Cell Proliferation | 1 | 2017 | 2480 | 0.080 |
Why?
| | Genetic Markers | 2 | 2005 | 342 | 0.080 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2011 | 196 | 0.080 |
Why?
| | Up-Regulation | 1 | 2013 | 851 | 0.080 |
Why?
| | Cell Death | 1 | 2011 | 375 | 0.080 |
Why?
| | Hepatocytes | 1 | 2010 | 211 | 0.080 |
Why?
| | Biomedical Research | 1 | 2016 | 694 | 0.080 |
Why?
| | Gene Expression Regulation | 3 | 2015 | 2590 | 0.080 |
Why?
| | Proto-Oncogene Proteins c-myb | 3 | 1999 | 10 | 0.080 |
Why?
| | Spinal Cord Injuries | 1 | 2013 | 231 | 0.080 |
Why?
| | Behavior, Animal | 1 | 2012 | 512 | 0.080 |
Why?
| | Cell Cycle Proteins | 1 | 2013 | 616 | 0.070 |
Why?
| | Repressor Proteins | 1 | 2012 | 420 | 0.070 |
Why?
| | Pyrazoles | 1 | 2012 | 425 | 0.070 |
Why?
| | Polymerase Chain Reaction | 1 | 2011 | 1047 | 0.070 |
Why?
| | Aging | 2 | 2023 | 1855 | 0.070 |
Why?
| | Kidney Diseases | 1 | 2012 | 403 | 0.070 |
Why?
| | Homeodomain Proteins | 1 | 2012 | 509 | 0.070 |
Why?
| | Glial Fibrillary Acidic Protein | 2 | 2007 | 102 | 0.070 |
Why?
| | Immunohistochemistry | 1 | 2011 | 1731 | 0.070 |
Why?
| | Adult | 7 | 2021 | 38201 | 0.070 |
Why?
| | Protein Biosynthesis | 2 | 2013 | 434 | 0.060 |
Why?
| | DNA | 2 | 2012 | 1438 | 0.060 |
Why?
| | Sleep | 1 | 2012 | 799 | 0.060 |
Why?
| | Mental Disorders | 1 | 2014 | 1096 | 0.060 |
Why?
| | Karyotyping | 2 | 2016 | 103 | 0.060 |
Why?
| | Regulatory-Associated Protein of mTOR | 1 | 2025 | 24 | 0.060 |
Why?
| | Clinical Trials as Topic | 1 | 2010 | 1034 | 0.060 |
Why?
| | Anxiety | 1 | 2012 | 1072 | 0.060 |
Why?
| | Synaptic Transmission | 1 | 2007 | 294 | 0.060 |
Why?
| | Neuronal Plasticity | 1 | 2007 | 302 | 0.050 |
Why?
| | Amino Acid Motifs | 2 | 2015 | 225 | 0.050 |
Why?
| | Death, Sudden, Cardiac | 1 | 2025 | 188 | 0.050 |
Why?
| | Membrane Potential, Mitochondrial | 2 | 2014 | 73 | 0.050 |
Why?
| | Mice, Nude | 2 | 2015 | 688 | 0.050 |
Why?
| | Centrosome | 1 | 2023 | 71 | 0.050 |
Why?
| | Hypertension, Pulmonary | 1 | 2014 | 1924 | 0.050 |
Why?
| | DNA Damage | 2 | 2016 | 422 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2025 | 3523 | 0.050 |
Why?
| | Molecular Sequence Data | 3 | 2015 | 2923 | 0.050 |
Why?
| | Neoplasm Metastasis | 1 | 2025 | 666 | 0.050 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2002 | 26 | 0.050 |
Why?
| | Binding Sites | 2 | 2015 | 1313 | 0.050 |
Why?
| | Electrocardiography | 1 | 2025 | 612 | 0.050 |
Why?
| | Genetic Predisposition to Disease | 3 | 2015 | 2339 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2005 | 600 | 0.040 |
Why?
| | Vaccines, Synthetic | 1 | 2021 | 132 | 0.040 |
Why?
| | Adverse Drug Reaction Reporting Systems | 1 | 2021 | 77 | 0.040 |
Why?
| | Drug Approval | 1 | 2021 | 91 | 0.040 |
Why?
| | Tumor Microenvironment | 1 | 2025 | 669 | 0.040 |
Why?
| | Malformations of Cortical Development | 1 | 2020 | 13 | 0.040 |
Why?
| | Haploinsufficiency | 1 | 2020 | 56 | 0.040 |
Why?
| | Stroke Volume | 1 | 2023 | 584 | 0.040 |
Why?
| | Genetic Variation | 1 | 2025 | 986 | 0.040 |
Why?
| | Advisory Committees | 1 | 2021 | 218 | 0.040 |
Why?
| | Seizures, Febrile | 1 | 2019 | 22 | 0.040 |
Why?
| | Patient Advocacy | 1 | 2020 | 75 | 0.040 |
Why?
| | Ventricular Function, Left | 1 | 2023 | 502 | 0.040 |
Why?
| | Selective Estrogen Receptor Modulators | 1 | 2019 | 32 | 0.040 |
Why?
| | Cell Survival | 2 | 2013 | 1123 | 0.040 |
Why?
| | Thyroid Nuclear Factor 1 | 1 | 2019 | 15 | 0.040 |
Why?
| | Odontogenesis | 1 | 1999 | 11 | 0.040 |
Why?
| | Digestive System | 1 | 1999 | 28 | 0.040 |
Why?
| | Culture Media | 1 | 2019 | 163 | 0.040 |
Why?
| | Machine Learning | 1 | 2024 | 517 | 0.040 |
Why?
| | Hair Follicle | 1 | 1999 | 47 | 0.040 |
Why?
| | Adenosine Deaminase | 2 | 1996 | 35 | 0.040 |
Why?
| | Tamoxifen | 1 | 2019 | 202 | 0.040 |
Why?
| | Kidney Tubules, Proximal | 1 | 2019 | 132 | 0.040 |
Why?
| | Models, Biological | 1 | 2006 | 1806 | 0.040 |
Why?
| | Thyroid Gland | 1 | 1999 | 92 | 0.040 |
Why?
| | In Situ Hybridization | 1 | 1999 | 319 | 0.040 |
Why?
| | Myofibroblasts | 1 | 2019 | 127 | 0.040 |
Why?
| | Inhibitory Postsynaptic Potentials | 1 | 2018 | 47 | 0.030 |
Why?
| | Oligodendrocyte Precursor Cells | 1 | 2017 | 19 | 0.030 |
Why?
| | Mitosis | 1 | 1999 | 192 | 0.030 |
Why?
| | Coculture Techniques | 1 | 2018 | 241 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2025 | 3392 | 0.030 |
Why?
| | Disease Susceptibility | 1 | 2019 | 349 | 0.030 |
Why?
| | Trachea | 1 | 1999 | 255 | 0.030 |
Why?
| | Strategic Planning | 1 | 2016 | 3 | 0.030 |
Why?
| | Zinostatin | 1 | 2016 | 1 | 0.030 |
Why?
| | Nucleic Acid Synthesis Inhibitors | 1 | 2016 | 17 | 0.030 |
Why?
| | Myosin Light Chains | 1 | 2015 | 28 | 0.030 |
Why?
| | Ethylnitrosourea | 1 | 2015 | 13 | 0.030 |
Why?
| | Fluorescence Polarization | 1 | 2015 | 26 | 0.030 |
Why?
| | Diffusion | 1 | 2015 | 121 | 0.030 |
Why?
| | Hybrid Cells | 1 | 1995 | 48 | 0.030 |
Why?
| | Genetic Complementation Test | 1 | 1995 | 66 | 0.030 |
Why?
| | Two-Hybrid System Techniques | 1 | 2015 | 57 | 0.030 |
Why?
| | Base Sequence | 2 | 1996 | 2174 | 0.030 |
Why?
| | Anisotropy | 1 | 2015 | 77 | 0.030 |
Why?
| | Methylmercury Compounds | 1 | 2014 | 8 | 0.030 |
Why?
| | NIH 3T3 Cells | 1 | 2015 | 148 | 0.030 |
Why?
| | Troponin I | 1 | 2015 | 81 | 0.030 |
Why?
| | Point Mutation | 1 | 1995 | 236 | 0.030 |
Why?
| | Genotype | 1 | 2019 | 1842 | 0.030 |
Why?
| | Introns | 1 | 1995 | 254 | 0.030 |
Why?
| | Goals | 1 | 2016 | 177 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2015 | 346 | 0.030 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2015 | 391 | 0.030 |
Why?
| | Myocardial Contraction | 1 | 2015 | 303 | 0.030 |
Why?
| | Axons | 1 | 2015 | 195 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2015 | 395 | 0.030 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2014 | 198 | 0.030 |
Why?
| | HeLa Cells | 1 | 1995 | 637 | 0.030 |
Why?
| | Genes, Lethal | 1 | 2013 | 30 | 0.020 |
Why?
| | RNA, Ribosomal, 18S | 1 | 2013 | 27 | 0.020 |
Why?
| | Manganese Compounds | 1 | 2012 | 2 | 0.020 |
Why?
| | United States | 3 | 2021 | 14938 | 0.020 |
Why?
| | Sequence Analysis, RNA | 1 | 2015 | 448 | 0.020 |
Why?
| | Terminology as Topic | 1 | 2014 | 243 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2851 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2015 | 728 | 0.020 |
Why?
| | Neurologic Examination | 1 | 2012 | 128 | 0.020 |
Why?
| | PAX6 Transcription Factor | 1 | 2012 | 21 | 0.020 |
Why?
| | Biomechanical Phenomena | 1 | 2015 | 817 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 1941 | 0.020 |
Why?
| | Homeostasis | 2 | 2007 | 614 | 0.020 |
Why?
| | Respiratory Mucosa | 1 | 2014 | 322 | 0.020 |
Why?
| | Age Factors | 1 | 1999 | 3256 | 0.020 |
Why?
| | Saccharomyces cerevisiae | 1 | 1995 | 553 | 0.020 |
Why?
| | Biosensing Techniques | 1 | 2012 | 133 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2015 | 2155 | 0.020 |
Why?
| | Neural Inhibition | 1 | 2012 | 177 | 0.020 |
Why?
| | Young Adult | 2 | 2018 | 13305 | 0.020 |
Why?
| | Phosphorylation | 1 | 2014 | 1760 | 0.020 |
Why?
| | Pregnancy | 1 | 2023 | 6829 | 0.020 |
Why?
| | Middle Aged | 3 | 2019 | 33604 | 0.020 |
Why?
| | Models, Molecular | 1 | 2015 | 1587 | 0.020 |
Why?
| | Reactive Oxygen Species | 1 | 2012 | 624 | 0.020 |
Why?
| | Risk Factors | 2 | 2014 | 10252 | 0.020 |
Why?
| | Pilot Projects | 1 | 2014 | 1765 | 0.020 |
Why?
| | Protein Binding | 1 | 2015 | 2225 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2019 | 5798 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2012 | 2049 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2019 | 6144 | 0.020 |
Why?
| | Nerve Degeneration | 1 | 2007 | 49 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2015 | 3307 | 0.020 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2007 | 104 | 0.020 |
Why?
| | Organ Culture Techniques | 1 | 2007 | 157 | 0.020 |
Why?
| | T-Lymphocytes | 1 | 1995 | 1986 | 0.020 |
Why?
| | Neocortex | 1 | 2007 | 38 | 0.020 |
Why?
| | Long-Term Potentiation | 1 | 2007 | 199 | 0.010 |
Why?
| | Biological Transport, Active | 1 | 2003 | 71 | 0.010 |
Why?
| | Gliosis | 1 | 2003 | 28 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2018 | 10923 | 0.010 |
Why?
| | Electrophysiology | 1 | 2003 | 217 | 0.010 |
Why?
| | Immunoenzyme Techniques | 1 | 2002 | 209 | 0.010 |
Why?
| | Hippocampus | 1 | 2007 | 929 | 0.010 |
Why?
| | Time Factors | 1 | 2012 | 6851 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2018 | 15909 | 0.010 |
Why?
| | Synapses | 1 | 2003 | 426 | 0.010 |
Why?
| | Aged | 1 | 2016 | 24024 | 0.010 |
Why?
| | Awards and Prizes | 1 | 1996 | 72 | 0.010 |
Why?
| | Hematopoiesis | 1 | 1996 | 193 | 0.010 |
Why?
| | Societies, Medical | 1 | 1996 | 839 | 0.010 |
Why?
| | Biomarkers | 1 | 2002 | 4092 | 0.010 |
Why?
|
|
Ess's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|